What's New at Charles River
   
 
 
   
   

Enhanced Parasitology Facility at Charles River Ireland
More Choice, Increased Capacity, Quicker Results

June 8, 2011 - Charles River is delighted to announce the expansion of our parasitology facility in the West of Ireland. Our fully validated, custom-built and energy-efficient facility of approximately 6,000 sq. ft. provides a significant increase in our capacity for tick production (EU and US strains). In addition, it allows us to expand into new species, such as sandflies and mosquitoes.

Charles River has over 30 years of experience providing solutions to the animal health industry in ectoparasitology and endoparasitology. With this development, we can now offer not only an extended range of species, but also larger study designs and improved scheduling to meet your program requirements.

Through our rapid in vitro screening service, our colonies of fleas and several species of ticks can be used to evaluate the potential of new candidate molecules. In addition, we can breed ectoparasites common to livestock species and companion animals.

Our range of study designs includes efficacy studies for both endo- and ectoparasite species, as well as the full range of regulatory studies. Regulatory studies include safety/tolerance, reproductive safety, pharmacokinetics and residue analysis - all of which meet FDA, US EPA, European EMA and VICH guidelines.

For more information about our enhanced parasitology facility or services, please contact us at 1.877.CRIVER.1 or email askcharlesriver@crl.com.


Related Information

 

 

   
Discover the full range of Charles River Products and Services
The Source

For more information, contact us at:

1.877.CRIVER.1 (1.877.274.8371)
askcharlesriver@crl.com

view all

News & Events

view all
May 13 - High-Throughput Screening for CNS ...
May 08 - Comparability Studies for Monoclon...
May 21-May 24 - Berlin, Germany - RDD Europe 2013
May 23-May 23 - East Lansing, Michigan, USA - The Ins and Outs of Transgenic Colongy Ma...

Charles River Laboratories, Inc.